Advertisement

Hypertensive Heart Disease, Ventricular Dysrhythmias, and Sudden Death

  • Franz H. Messerli
  • Leszek Michalewicz
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 432)

Abstract

Left ventricular hypertrophy (LVH) has been identified as one of the strongest pressure-independent risk factors for sudden death, acute myocardial infarction, congestive heart failure and other cardiovascular morbidity and mortality. [1,2,3] These findings clearly abolish the concept of LVH being a benign adaptive process serving to compensate for the increased hemodynamic burden. Fig. 1. Based on these epidemiologic observations, a patophysiologic or electrophysiologic chain of evidence linking hypertension, LVH, and sudden death has been put forward. Although it is unclear whether a reduction in LVH confers benefit over and above the benefit of lowering blood pressure alone, the effects various antihypertensive agents have on LVH come under scrutiny.

Keywords

Left Ventricular Hypertrophy Ventricular Arrhythmia Sudden Cardiac Death Left Ventricular Mass Hypertensive Heart Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983;75(Suppl 3A):4–11.PubMedCrossRefGoogle Scholar
  2. 2.
    Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated hypertension. Ann Intern Med 1991;114:345–352.PubMedGoogle Scholar
  3. 3.
    Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death: increased ventricular ectopy activity in left ventricular hypertrophy. Am J Med 1984;77:18–22.PubMedCrossRefGoogle Scholar
  4. 4.
    Messerli FH, Nunez BD, Nunez MM, Garavaglia GE, Schmieder RE, Ventura HO. Hypertension and sudden death: Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. Arch Intern Med 1989;149(Suppl 6): 1263–1267.PubMedCrossRefGoogle Scholar
  5. 5.
    Levy D, Anderson KM, Savage DD, et al: Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988;108:7–13.PubMedGoogle Scholar
  6. 6.
    McLenachan JM, Henderson E, Morris KI, et al: Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317:787–792.PubMedCrossRefGoogle Scholar
  7. 7.
    Bikkina M, Larson MG, Levy D: Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 1993;22:1111–1116.PubMedCrossRefGoogle Scholar
  8. 9.
    Messerli FH, Glade LB, Elizardi DG, Dreslinski GR, Dunn FG, Frohlich ED. Cardiac rhythm, arterial pressure, and urinary catecholamines in hypertension with and without left ventricular hypertension. Am J Cardiol 1981;47:480.CrossRefGoogle Scholar
  9. 10.
    Loaldi A, Pepi M, Agostoni PG, et al. Cardiac rhythm in hypertension assessed through 24-hour ambulatory electrocardiographic monitoring effects of load manipulation with atenolol, verapamil, and nifedipine. Br Heart J 1983;50:118–126.PubMedCrossRefGoogle Scholar
  10. 11.
    McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317:787–792.PubMedCrossRefGoogle Scholar
  11. 12.
    Aronow WS, Epstein S, Schwartz KS, Koenigsberg M. Correlation of complex ventricular arrhythmias detected by ambulatory electrocardiographic monitoring with echocardiographic left ventricular hypertrophy in persons older than 62 years in a long-term health care facility. Am J Cardiol 1987;60:730–732.PubMedCrossRefGoogle Scholar
  12. 13.
    Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Study. Am J Cardiol 1987;60:560–565.PubMedCrossRefGoogle Scholar
  13. 14.
    Lavie CJ Jr, Nunez BD, Garavaglia GE, Messerli FH. Hypertensive concentric hypertrophy: When is ventricular ectopic activity increased? South Med J 1988;81:696–700.PubMedCrossRefGoogle Scholar
  14. 15.
    Papademetriou V, Notargiacomo A, Heine D, Fletcher R, Freis E. Ventricular arrhythmias in patients with essential hypertension [Abstract]. J Am Coll Cardiol 1989;1313:105A.Google Scholar
  15. 16.
    Szlachcic J, London M, Tubau JF, O’Kelly B, Mangano D. Incidence of serious ventricular arrhythmias during surgery in hypertensives with left ventricular hypertrophy [Abstract]. J Am Coll Cardiol 1989;13:105A.Google Scholar
  16. 17.
    James MA, Jones JV. Ventricular arrhythmia in untreated hypertensive patients compared with a matched normal population. J Hypertens 1989;7:409–415.PubMedCrossRefGoogle Scholar
  17. 18.
    Ferrara N, Furgi G, Longobardi G, Nicolino A, Acanfora D, Leosco D, Rengo F. Relation between age, left ventricular mass and ventricular arrhythmias in patients with hypertension. J Hum Hypertens 1995;9(7): 881–587.Google Scholar
  18. 19.
    Siegel D, Cheitlin MD, Blaek DM, Seeley D, Hearst N, Hulley SB. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol 1990;65:742–747.PubMedCrossRefGoogle Scholar
  19. 20.
    Galinier M, Fermond B, Lambert V, et al. When is a search for ventricular arrhythmias necessary in hypertensive patients. J Hypertens 1991;9:874–875.CrossRefGoogle Scholar
  20. 21.
    Melina D, Colivicchi F, Guerrera G, Santoliquido A. Rhythm of disturbances in essential hypertension [Letter]. J Human Hypertens 1991; 5:233.Google Scholar
  21. 22.
    Ghali JK, Kadakia S, Cooper RS, Liao YL. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol 1991; 17:1277–1282.PubMedCrossRefGoogle Scholar
  22. 23.
    Novo S, Barbagallo M, Abrignani M, Alaimo G, Nardi E, Corrao S, Papadia C, Strano A. Cardiac arrhythmias as correlated with the circadian rhythm of arterial pressure in hypertensive subjects with and without left ventricular hypertrophy. Eur J Clin Pharmacol 1990;39(Suppl 1):49–51.CrossRefGoogle Scholar
  23. 24.
    Messerli FH, Grodzicki T. Hypertension, left ventricular hypertrophy, ventricular arrthythmias and sudden death. Eur Heart J 1992;13(Suppl D):66–69.PubMedCrossRefGoogle Scholar
  24. 25.
    Nunez BD, Lavie CJ, Messerli FH, Scmieder RE, Garavaglia GE, Nunez M. Comparision of diastolic left ventricular filling and cardiac dysrhythmias in hypertensive patients with and without isolated septal hypertrophy. Am J Cardiol 1994;74(6):585–589.PubMedCrossRefGoogle Scholar
  25. 26.
    Vardas PE, Simandirakis EN, Parthenakis FI, Manios EG, Eleftherakis NG, Terzakis DE. Study of late potentials and ventricular arrhythmias in hypertensive patients with normal electrocardiograms. Pacing Clin Electrophysiol 1994;(4 Pt 1 ):577–584.Google Scholar
  26. 27.
    Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Zampi I, Battistelli M, Gattobigio R, Sacchi N, Porcellati C. Association between persistent pressure overload and ventricular arrhythmias in essential hypertension. Hypertension 1996;2:284–289.CrossRefGoogle Scholar
  27. 28.
    Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982;306:1018–1022.PubMedCrossRefGoogle Scholar
  28. 29.
    O’Gorman DJ, Sheridan DJ. Abnormalities of the coronary circulation associated with left ventricular hypertrophy. Clin Sci 1991;81:703–713.PubMedGoogle Scholar
  29. 30.
    Houghton JL, Prisant LM, Carr AA, von Dohlen TW, Frank MJ. Relationship of left ventricular mass to impairment of coronary vasodilator reserve in hypertensive heart disease. Am Heart J 1991:121(4 Pt 1): 1107–1112.PubMedCrossRefGoogle Scholar
  30. 31.
    Lucarini AR, Picano E, Salveti A. Coronary microvascular disease in hypertensives. Clin Exp Hypertens 1992;A14:55–66.CrossRefGoogle Scholar
  31. 32.
    Houghton JL, Carr AA, Prisant LM, et al. Morphologic, hemodymanic and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia. Am J Cardiol 1992;69:219–224.PubMedCrossRefGoogle Scholar
  32. 33.
    Harrison DG, Marcus ML, Dellsperger KC, Lamping KG, Tomanek RJ. Pathophysiology of myocardial perfusion in hypertension. Circulation 1991;83(Suppl III):III-14–III-18.Google Scholar
  33. 34.
    Burke AP, Farb A, Liang YH, Smialek J, Virmani R. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death. Circulation 1996;94(12):3138–3145.PubMedCrossRefGoogle Scholar
  34. 35.
    Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336(18):1276–1282.PubMedCrossRefGoogle Scholar
  35. 36.
    Levy D, Anderson KM, Plehn J, Savage DD, Christiansen JC, Castelli WP. Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on onehour ambulatory electrocardiographic monitoring. Am J Cardiol 1987;59:836–840.PubMedCrossRefGoogle Scholar
  36. 37.
    Palatini P, Maraglino G, Accurso V, Sturaro M, Toniolo G, Dovigo P, Baccillieri S. Impaired left ventricular filling in hypertensive left ventricular hypertrophy as a marker of the presence of an arrhythmogenic substrate. Br Heart J 1995;73(3):258–262.PubMedCrossRefGoogle Scholar
  37. 38.
    Polese A, De Cesare N, Fabbiocchi N, Loaldi A, Montorsi P, Guazzi MD. Coronary autoregulation in hypertension: Correlation with left vetricular mass [Abstract]. J Am Coll Cardiol 1990; 15:111A.CrossRefGoogle Scholar
  38. 39.
    Nunez BD, Messerli FH, Garavaglia GE, Schmieder RE. Exagerrated atrial and ventricular excitability in hypertensive patients with isolated septal hypertrophy (ISH) (abstr). J AM Coll Cardiol 1987;9:225.CrossRefGoogle Scholar
  39. 40.
    Toyoshima H, Park Y-D, Ishikawa Y, et al. Effects of ventricular hypertrophy on conduction velocity of activation front in the ventricular myocardium. Am J Cardiol 1982;49:1938–1945.PubMedCrossRefGoogle Scholar
  40. 41.
    Leyton RA, Sonneblick EH. The ultrastructure of the failing heart. Am J Med Sci 1969;258:304–327.PubMedCrossRefGoogle Scholar
  41. 42.
    Sideris DA, Kontoyannis DA, Miehalis L, Adraetas A, Moulopoulos SD. Acute changes in blood pressure as a cause of cardiac arrhythmias. Eur Heart J 1987;8:45–52.PubMedCrossRefGoogle Scholar
  42. 43.
    Sideris DA, Toumanidis ST, Kostis EB, Diakos A, Moulopoulos SD. Arrhythmogenic effect of high blood pressure: Some observation on its mechanisms. Cardiovasc Res 1989;23:983–992.PubMedCrossRefGoogle Scholar
  43. 44.
    James MA, Jones JV. Systolic wall stress and ventricular arrhythmia: The role of acute change in blood pressure in the isolated working rat heart. Clin Sci 1990;79:499–504.PubMedGoogle Scholar
  44. 45.
    Bustamante JO, Ruknudin A, Sachs F. Stretch-activated channels in heart cells: relevance to cardiac hypertrophy. J Cardiovasc Pharmacol 1991;17(Suppl 2):S110–S113.PubMedCrossRefGoogle Scholar
  45. 46.
    Schwartz P, LaRovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85(Suppl I): I-77–I-91.Google Scholar
  46. 47.
    Anderson JL, Rodier HE, Green LS. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol 1983;51:1196–1202.PubMedCrossRefGoogle Scholar
  47. 48.
    Palatini P, Julius S. Heart rate and cardiovascular risk. J Hypertens 1997; 15(1):3–17.PubMedCrossRefGoogle Scholar
  48. 49.
    Amerena J, Julius S. The role of the autonomic nervous system in hypertension. Hypertens Res 1995; 18(2): 99–110.PubMedCrossRefGoogle Scholar
  49. 50.
    Paul M, Ganten D. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotension system. J Cardiovasc Pharmacol 1992;19(Suppl 5):S51–S58.PubMedGoogle Scholar
  50. 51.
    Harrap SB, Mitchell GA, Casley DJ, Mirakian C, Doyle AE. Angiotensin II, sodium, and cardiovascular hypertrophy in spontaneously hypertensive rats. Hypertension 1993;21:50–55.PubMedCrossRefGoogle Scholar
  51. 52.
    Kowey PR, Friechling TD, Sewter J, et al. Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade. Circulation 1991;83:2067–2075.PubMedCrossRefGoogle Scholar
  52. 53.
    Clementy J, Coste P, Dallocchio M, Bricaud H. Data of programmed ventricular stimulation in left ventricular hypertrophy of hypertensive origin [French]. Annales de Cardiologie et d’ Angiologie 1989;38: 297–303.Google Scholar
  53. 54.
    Vester EG, Kuhls S, Ochiulet-Vester J, Vogt M, Strauer BE. Electrophysiological and therapeutic implication of cardiac arrhythmias in hypertension. Eur Heart J 1992;13(Suppl D):70–81.PubMedCrossRefGoogle Scholar
  54. 55.
    Singh JP, Sleight P, Kardos A, Hart G. QT interval dynamics and heart rate variability preceding a case of cardiac arrest. Heart 1997;77(4):375–377.PubMedGoogle Scholar
  55. 56.
    Aronow WS, Epstein S, Koenigsberg M, Schwartz KS: Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. Am J Cardiol 1988;62(16): 1124–1125.PubMedCrossRefGoogle Scholar
  56. 57.
    Dahlöf B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992;5:95–110.PubMedGoogle Scholar
  57. 58.
    Böhlen L, Weidmann BL, de Courten M, et al: Antihypertensive drug effects on left ventricular hypertrophy: meta-analysis considering duration of treatment (abstract). J Hypertens 1994;12(Suppl 3):S140.Google Scholar
  58. 59.
    Cruickshank JM, Lewis J, Moore V, Dodd C: Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6:85–90.PubMedGoogle Scholar
  59. 60.
    Schmieder RE, Martus P, Klingbeil A: Reversal of left ventricular hypertrophy in essential hypertension. JAMA 1996;275:1507–1513.PubMedCrossRefGoogle Scholar
  60. 61.
    Pfeffer MA, Braunwald E, Moye LA, et al: Effect of Captopril on mortality and morbidity in patients with LV dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:669–677.PubMedCrossRefGoogle Scholar
  61. 62.
    Dzau VJ: Local expression and pathophysiological role of renin angiotensin in the blood vessels and heart, in Grobecker H, Heusch G, Strauer BE (eds): Angiotensin and Heart. New York, Springer Verlag, 1993, pp 1–14.CrossRefGoogle Scholar
  62. 63.
    Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ: Circulation 1997;95(8): 2007–14.PubMedCrossRefGoogle Scholar
  63. 64.
    Dahlöf B, Hansson L: Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide. J Hypertens 1992;10:1513–1524.PubMedCrossRefGoogle Scholar
  64. 65.
    Dahlöf B, Hansson L: The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide. J Intern Med 1993;234:271–279.PubMedCrossRefGoogle Scholar
  65. 66.
    Gonzáles-Fernández RA, Rivera M, Rodriguez PJ, et al: Prevalence of ectopic ventricular activity after left ventricular mass regression. Am J Hypertens 1993;6(suppl):308–313.Google Scholar
  66. 67.
    Corea L, Bentivoglio M, Verdecchia P. Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension. Reversal by atenolol treatment. Hypertension 1983;5:837–843.Google Scholar
  67. 68.
    Rowlands DB, Glover DR, Stallard TJ, Littler WA. Control of blood pressure and reduction of echocardiog-raphically assessed left ventricular mass with once-daily timolol. Br J Clin Pharmacol 1982;14:89–95.PubMedCrossRefGoogle Scholar
  68. 69.
    Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Page V, Ghadirian P, LeLorier J, Hamet P. J Hypertens 1996; 14(10):1237–1245.PubMedCrossRefGoogle Scholar
  69. 70.
    Goldstein S. Beta blockers in hypertensive and coronary heart disease. Arch Intern Med 1996; 156(12): 1267–1276.PubMedCrossRefGoogle Scholar
  70. 71.
    Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, Cobb L, Rautaharju PM, Copass MK, Wagner EH: N Engl J Med 1994; 330(26): 1852–7.PubMedCrossRefGoogle Scholar
  71. 72.
    Caralis PV, Materson BJ, Perez-Stable E: Potassium and diuretic-induced ventricular arrhythmias in ambulatory hypertensive patients. Miner Electrolyte Metab 1984,10:148–154.PubMedGoogle Scholar
  72. 73.
    Hollifield JW. Potassium and magnesium abnormalities: diuretics and arrhythmias in hypertension. Am J Med 1984;77(Suppl 5A):28–32.PubMedCrossRefGoogle Scholar
  73. 74.
    Levy D, Salomon M, D’Agostino RB, Belangen-AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994;90(4): 1786–1793.PubMedCrossRefGoogle Scholar
  74. 75.
    Yurenev AP, Dyakonova HG, Novikov ID, et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial. Am J Hypertens 1992;5(6 Pt 2): 182S–189S.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Franz H. Messerli
    • 1
  • Leszek Michalewicz
    • 1
  1. 1.Department of Internal Medicine Section on Hypertensive DiseasesOchsner Clinic and Alton Ochsner Medical FoundationNew OrleansUSA

Personalised recommendations